Schoenherr has advised Grupa Zywiec on executing a conditional agreement to sell the Lezajsk brewery to Mycofeast. Rymarz Zdort Maruta advised Mycofeast.
The transaction remains contingent on regulatory approval. "The agreement is a significant milestone for both parties and signals a new chapter for the brewery," Schoenherr reported.
Grupa Zywiec is the Polish subsidiary of the Heineken Group. The company recently announced changes to its production strategy in Poland, focusing on consolidating operations in four key breweries.
Mycofeast is an industrial biotechnology company.
The Schoenherr team included Partner Marcin Czaprowski and Associates Maciej Korzon and Kamil Jurzak.
The Rymarz Zdort Maruta team included Managing Partner Pawel Zdort, Partner Marcin Pieklak, Senior Associates Aleksandra Kabac, Marta Szczepkowska, Tomek Bakowski, Hanna Bachowska, Klaudia Cholewa, and Michal Matysiak, Associate Szymon Marciniak, Junior Associate Karol Wojtkowski, Paralegal Barbara Gawin, and Expert Pawel Mirosz.
